Alexandria Real Estate Equities
ARE
#2366
Rank
โ‚น759.09 B
Marketcap
โ‚น4,411
Share price
0.86%
Change (1 day)
-34.01%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2026 (TTM): -โ‚น50.48 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are โ‚น2.76 Billion. In 2025 the company made an earning of -โ‚น95.77 Billion a decrease over its 2024 earnings that were of โ‚น67.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น50.48 Billion-47.3%
2025 -โ‚น95.77 Billion-242.13%
2024 โ‚น67.37 B96.11%
2023 โ‚น34.35 B-53.56%
2022 โ‚น73.98 B-3.96%
2021 โ‚น77.04 B-20.26%
2020 โ‚น96.61 B72.88%
2019 โ‚น55.88 B3.11%
2018 โ‚น54.19 B73.54%
2017 โ‚น31.22 B464.88%
2016 โ‚น5.52 B-77.32%
2015 โ‚น24.37 B36.31%
2014 โ‚น17.87 B-10.81%
2013 โ‚น20.04 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น668.11 B-1,282.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.249 T-5,849.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น995.06 B-1,860.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น189.11 Billion 234.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น112.20 B-298.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.152 T-2,138.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น108.78 B-292.46%๐Ÿ‡บ๐Ÿ‡ธ USA